Clinicians may underaddress Black men's PSA test inquiries
Black men face clinician barriers in PSA test discussions.
Why it matters
- Higher prostate cancer mortality in Black men.
- Early PSA tests can cut mortality by 30%.
By the numbers
- 6% of primary-care clinicians see PSA tests as key.
- Black men: 60-80% higher prostate cancer incidence.
The big picture
- Clinicians may overlook Black men's higher risk.
- Guidelines may need updates for racial disparities.
What they're saying
- Personalized care is essential.
- Fear of false positives may deter PSA tests.
Caveats
- Small, regional study (29 men, 63 clinicians).
- Mixed guidelines affect clinician approaches.
What’s next
- USPSTF may update guidelines for high-risk groups.
- More clinician education on racial disparities needed.